Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Inoperable œsophageal Cancer × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 265 Leukemia 183 Carcinoma, Non-Small-Cell Lung 167 Lymphoma 159 Lung Neoplasms 148 Prostatic Neoplasms 132 Precursor Cell Lymphoblastic Leukemia-Lymphoma 130 Ovarian Neoplasms 117 Colorectal Neoplasms 114 Sarcoma 108 Central Nervous System Neoplasms 107 Head and Neck Neoplasms 97 Leukemia, Myeloid, Acute 94 Multiple Myeloma 93 Squamous Cell Carcinoma of Head and Neck 83 Rectal Neoplasms 77 Colonic Neoplasms 71 Uterine Cervical Neoplasms 65 Neoplasm Metastasis 65 Neuroblastoma 64 Carcinoma, Ovarian Epithelial 64 Brain Neoplasms 64 Neoplasms 63 Fallopian Tube Neoplasms 62 Lymphoma, Large B-Cell, Diffuse 61 Astrocytoma 59 Melanoma 58 Leukemia, Lymphocytic, Chronic, B-Cell 56 Burkitt Lymphoma 56 Hodgkin Disease 55

Interventions

Nivolumab 1 Ipilimumab 1 Chemoradiotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03437200 2023-02-21

CRUCIAL

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Terminated

Inoperable œsophageal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡